Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: MSI-1436C
Sponsor: Northwell Health
Collaborators: DepYmed Inc.